AI सारांश
हमने herzuma के लिए 6 लाइव परिणाम देखे और पहले तुलना करने लायक 3 विकल्प चुने।
इस छोटी सूची में सबसे मजबूत विषय Oncology और Biosimilar हैं।
Compare with TopFind
लाइव खोज
लाइव परिणाम लोड हो रहे हैं
TopFind आपकी खोज के लिए नए मिलान ला रहा है।
लाइव खोज
TopFind आपकी खोज के लिए नए मिलान ला रहा है।
हमने herzuma के लिए 6 लाइव परिणाम देखे और पहले तुलना करने लायक 3 विकल्प चुने।
इस छोटी सूची में सबसे मजबूत विषय Oncology और Biosimilar हैं।
स्रोत: Celltrion Healthcare Singapore Private Limited
विवरण
Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies.
सबसे उपयुक्त
HER2 Positive cancer care, Breast cancer patients और Affordable trastuzumab access
रेटिंग
स्रोत: Celltrion Healthcare Philippines Inc.
विवरण
Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics.
सबसे उपयुक्त
HER2 Positive cancer, Oncology therapy और Biosimilar oncology
रेटिंग
स्रोत: Celltrion Healthcare
विवरण
Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials.
सबसे उपयुक्त
HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy और Oncology infusion treatment
रेटिंग
| तुलना करें | Herzuma | Herzuma (Trastuzumab) | Herzuma (Trastuzumab) |
|---|---|---|---|
| स्रोत | Celltrion Healthcare Singapore Private Limited | Celltrion Healthcare Philippines Inc. | Celltrion Healthcare |
| विवरण | Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies. | Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics. | Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials. |
| सबसे उपयुक्त | HER2 Positive cancer care, Breast cancer patients और Affordable trastuzumab access | HER2 Positive cancer, Oncology therapy और Biosimilar oncology | HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy और Oncology infusion treatment |
| कार्रवाई | |||
| रेटिंग |
अगर आप सबसे संतुलित विकल्प से शुरू करना चाहते हैं, तो मेरी सलाह है:
"Herzuma से Celltrion Healthcare Singapore Private Limited."
मैंने इसे इसलिए चुना क्योंकि Herzuma is a subsidy-eligible trastuzumab biosimilar that ensures affordability and accessibility for breast and gastric cancer patients in Singapore.